https://www.benzinga.com/quote/HNSPF/earnings
Hansoh Pharmaceutical Gr Earnings Estimates, EPS & Revenue | OTC:HNSPF | Benzinga
Discover Hansoh Pharmaceutical Gr stock earnings estimates, EPS, and revenue analysis with Benzinga. Stay informed on HNSPF's financial performance.
earnings estimatespharmaceuticalgrepsrevenue
https://pharma.economictimes.indiatimes.com/news/mergers-and-acquisitions/merck-signs-up-to-2-bln-obesity-drug-deal-with-chinese-biotech-hansoh/116439710
Pharmaceutical Industry: Merck signs up to $2 bln obesity drug deal with Chinese biotech Hansoh,...
Pharmaceutical Industry: Under the deal, Merck will pay $112 million upfront and Hansoh will be eligible to receive up to $1.9 billion in milestone payments...
https://www.benzinga.com/24/12/42597807/stock-of-the-day-where-does-the-merck-downtrend-end
Merck & Co (MRK) technical analysis - HANSOH PHARMACEUTICAL GP by Hansoh Pharmaceutical Group Co...
technical analysismerckcomrkpharmaceutical
https://ec2-13-251-157-120.ap-southeast-1.compute.amazonaws.com/flash-news/viking-shares-tumble-after-merck-inks-deal-with-hansoh-pharma/
Viking shares tumble after Merck inks deal with Hansoh Pharma - Trade Savi
Dec 18, 2024 - Viking shares declined by 5.5% following a licensing agreement between Hansoh Pharma and Merck regarding the development of a new metabolic disorder treatment.